secwatch.observer — SEC 8-K summary
======================================

Issuer:     HeartSciences Inc. (HSCS)
CIK:        0001468492
Form:       8-K
Filed at:   2026-05-06T23:59:59+00:00
Accession:  0001213900-26-052872
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

HeartSciences annual meeting approves director, stock plan, auditor; officer exculpation fails
--------------------------------------------------------------------------------

- Andrew Simpson re-elected Class III director with 577,840 for, 107,738 withheld, 1,288,285 broker non-votes.
- Amendment to 2023 Employee Stock Purchase Plan approved, increasing reserved shares to 1,250,000.
- Proposal to amend certificate of formation for officer exculpation under Texas law did not pass; needed majority of outstanding shares.
- Haskell & White LLP ratified as independent auditor for FY2026 with 1,872,912 votes for.
- Adjournment proposal approved (1,784,662 for) to allow further proxy solicitation if needed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1468492/000121390026052872/0001213900-26-052872-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1468492/000121390026052872/ea0289301-8k_heart.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-052872

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer